Join Navigant at the 14th Annual CBI Pharmaceutical Compliance Congress held April 26-28 in Washington, D.C. This event is a must-attend for compliance excellence, attracting more than 500 industry leaders annually and stakeholders of the highest caliber in life sciences compliance.
Saul Helman, managing director at Navigant, will provide opening remarks for Track 1 - Promotional Compliance on Thursday, April 27. On the same day, Stephanie Lewko, associate director at Navigant, will lead a panel discussing Conduct Predictive Analytics to Identify Areas of High Risk.
Managing directors Darin Bielby, Julie DeLong, Mark Farrar, Casey Horton and managing consultant, Johna Carufel will also be in attendance.